<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PPP1R15A Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>PPP1R15A</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>PPP1R15A</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=PPP1R15A" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">46 edges</a></td>
</tr>
</table>
PPP1R15A encodes protein phosphatase 1 regulatory subunit 15A (GADD34), an adaptive stress-response factor that terminates one arm of the [integrated stress response](/mechanisms/integrated-stress-response) by promoting dephosphorylation of eIF2alpha.[@novoa2001][@brush2003] In [neurons](/entities/neurons) and glia, this feedback node helps determine whether acute stress resolves with translational recovery or progresses toward persistent proteostasis failure and cell injury.[@scheper2015][@tsaytler2011]
PPP1R15A is typically low at baseline and strongly inducible by ER stress, amino-acid deprivation, viral response pathways, and DNA damage programs converging on ATF4/CHOP transcriptional signaling.[@novoa2001][@hollien2006] Because [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis) all show sustained proteotoxic and bioenergetic stress signatures, PPP1R15A has become a mechanistically relevant modifier rather than a single-gene disease driver.[@scheper2015][@halliday2015]
PPP1R15A is located on chromosome 19q13 and encodes a stress-inducible scaffold that recruits catalytic PP1 phosphatase to phospho-eIF2alpha substrates.[@novoa2001][@brush2003] Functionally, PPP1R15A contrasts with its constitutively expressed paralog PPP1R15B (CReP): PPP1R15A is recruited under high-stress conditions, while PPP1R15B sustains tonic baseline dephosphorylation.[@brush2003][@crespillocasado2017]
The core architecture includes:
Under proteotoxic stress, PERK and related kinases increase eIF2alpha phosphorylation, reducing global translation while favoring selective stress transcripts (ATF4, CHOP, and PPP1R15A itself).[@novoa2001][@scheper2015] PPP1R15A-mediated dephosphorylation then restores translational flux. This loop is adaptive if stress is transient, but can become maladaptive when chronic neurodegenerative stress repeatedly reactivates ISR circuits.[@scheper2015][@halliday2015]
In tauopathy, synucleinopathy, and [TDP-43](/mechanisms/tdp-43-proteinopathy) proteinopathy models, prolonged ISR activity is a recurrent feature. PPP1R15A modulation changes the duration of translational repression and therefore the kinetics of chaperone supply, synaptic protein renewal, and apoptotic signaling thresholds.[@tsaytler2011][@halliday2015][@moreno2012]
Human AD tissue and model systems consistently show ISR activation with elevated p-eIF2alpha and ATF4-related stress transcription. PPP1R15A is best interpreted as a compensatory branch of this axis, with context-dependent net effects.[@scheper2015][@tsaytler2011] Early/intermittent activation may aid recovery; persistent induction may coincide with unstable translational homeostasis and synaptic dysfunction.[@scheper2015][@halliday2015]
Dopaminergic neurons face mitochondrial and proteostatic stress from [alpha-synuclein](/proteins/alpha-synuclein) burden and oxidative load. ISR engagement is documented in several PD-relevant paradigms, and PPP1R15A is a plausible downstream regulator of translation-reset timing rather than a primary pathogenic lesion.[@tsaytler2011][@mercado2016]
ALS and FTD models with TDP-43, SOD1, [C9orf72](/entities/c9orf72), and FUS perturbations show pronounced stress-granule and ISR involvement. PPP1R15A sits at a tractable node where stress adaptation, translational arrest, and degeneration trajectories intersect.[@halliday2015][@moreno2012]
Pharmacologic interest in PPP1R15A arises from attempts to rebalance ISR duration:
Priority translational readouts include:
The following diagram shows the key molecular relationships involving PPP1R15A Gene discovered through SciDEX knowledge graph analysis:
Sources: [GTEx Portal v10](https://gtexportal.org/home/gene/ppp1r15a) | [Allen Brain Atlas](https://www.brain-map.org/)
| Rank | Tissue | Median TPM |
|------|--------|------------|
| 1 | Lung | 255.78 |
| 2 | Adipose Visceral Omentum | 227.56 |
| 3 | Nerve Tibial | 210.78 |
| 4 | Artery Aorta | 203.42 |
| 5 | Skin Not Sun Exposed Suprapubic | 194.88 |
| 6 | Fallopian Tube | 174.59 |
| 7 | Artery Tibial | 161.69 |
| 8 | Skin Sun Exposed Lower leg | 157.55 |
| 9 | Whole Blood | 156.84 |
| 10 | Artery Coronary | 156.39 |
| 11 | Uterus | 151.16 |
| 12 | Adipose Subcutaneous | 146.33 |
| 13 | Bladder | 139.05 |
| 14 | Ovary | 130.06 |
| 15 | Vagina | 125.13 |
Highest expression outside brain: Lung (255.78 TPM)